Suchergebnisse - "Krackhardt, Angela M"

PubPharm (5)

1

Progress in cancer immunotherapy

enthalten in: MMW Fortschritte der Medizin | 2017

von Krackhardt, A. | Heinrich, B.

2

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2017

von Zimmer, L. | Apuri, S. | Eroglu, Z. | +17

3

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Zimmer, L. | Goldinger, S. | Hofmann, L. | +25

4

Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Hofmann, L. | Forschner, A. | Loquai, C. | +25

5

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037) : a randomised, controlled, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2015

von Weber, J. | D'Angelo, S. | Minor, D. | +25

CommentIn: Lancet Oncol. 2015 Apr;16(4):350-1. - PMID 25795404

1
[1]